474 related articles for article (PubMed ID: 12665485)
1. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
3. Mechanical strain-induced human vascular matrix synthesis: the role of angiotensin II.
Stanley AG; Patel H; Knight AL; Williams B
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):32-5. PubMed ID: 11967796
[TBL] [Abstract][Full Text] [Related]
4. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.
Kang DH; Park SK; Lee IK; Johnson RJ
J Am Soc Nephrol; 2005 Dec; 16(12):3553-62. PubMed ID: 16251237
[TBL] [Abstract][Full Text] [Related]
5. Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells.
Nickenig G; Murphy TJ
Mol Pharmacol; 1996 Oct; 50(4):743-51. PubMed ID: 8863818
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.
Lassègue B; Alexander RW; Nickenig G; Clark M; Murphy TJ; Griendling KK
Mol Pharmacol; 1995 Oct; 48(4):601-9. PubMed ID: 7476884
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate inhibits interleukin-6- and angiotensin II-induced production of C-reactive protein in vascular smooth muscle cells.
Peng N; Liu JT; Guo F; Li R
Life Sci; 2010 Mar; 86(11-12):410-5. PubMed ID: 20100497
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
Chen J; Huang L; Song M; Yu S; Gao P; Jing J
J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle.
Sung CP; Arleth AJ; Storer BL; Ohlstein EH
J Pharmacol Exp Ther; 1994 Oct; 271(1):429-37. PubMed ID: 7965744
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells.
Hu ZW; Kerb R; Shi XY; Wei-Lavery T; Hoffman BB
J Pharmacol Exp Ther; 2002 Nov; 303(2):563-73. PubMed ID: 12388637
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.
Castejon AM; Zollner E; Tristano AG; Cubeddu LX
J Cardiovasc Pharmacol; 2007 Dec; 50(6):708-11. PubMed ID: 18091590
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor.
Wassmann S; Stumpf M; Strehlow K; Schmid A; Schieffer B; Böhm M; Nickenig G
Circ Res; 2004 Mar; 94(4):534-41. PubMed ID: 14699015
[TBL] [Abstract][Full Text] [Related]
14. Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta.
Viswanathan M; Strömberg C; Seltzer A; Saavedra JM
J Clin Invest; 1992 Nov; 90(5):1707-12. PubMed ID: 1331171
[TBL] [Abstract][Full Text] [Related]
15. alpha8beta1 Integrin expression in the rat carotid artery: involvement in smooth muscle cell migration and neointima formation.
Zargham R; Thibault G
Cardiovasc Res; 2005 Mar; 65(4):813-22. PubMed ID: 15721861
[TBL] [Abstract][Full Text] [Related]
16. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase.
Dechend R; Viedt C; Müller DN; Ugele B; Brandes RP; Wallukat G; Park JK; Janke J; Barta P; Theuer J; Fiebeler A; Homuth V; Dietz R; Haller H; Kreuzer J; Luft FC
Circulation; 2003 Apr; 107(12):1632-9. PubMed ID: 12668498
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells.
di Gioia CR; van de Greef WM; Sperti G; Castoldi G; Todaro N; Ierardi C; Pieruzzi F; Stella A
Biochem Biophys Res Commun; 2000 Dec; 279(3):965-9. PubMed ID: 11162458
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury.
Hur KY; Seo HJ; Kang ES; Kim SH; Song S; Kim EH; Lim S; Choi C; Heo JH; Hwang KC; Ahn CW; Cha BS; Jung M; Lee HC
Eur J Pharmacol; 2008 May; 586(1-3):226-33. PubMed ID: 18387604
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II activates intermediate-conductance Ca2+ -activated K+ channels in arterial smooth muscle cells.
Hayabuchi Y; Nakaya Y; Yasui S; Mawatari K; Mori K; Suzuki M; Kagami S
J Mol Cell Cardiol; 2006 Dec; 41(6):972-9. PubMed ID: 16919291
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor induces up-regulation of AT(1)-receptor gene expression in vascular smooth muscle cells.
Müller C; Reddert A; Wassmann S; Strehlow K; Böhm M; Nickenig G
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):273-7. PubMed ID: 11881037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
